Trends in the antimicrobial susceptibility among Chinese neonates from 2012 to 2021: a multicenter study

Zhanghua Yin1, Jintong Tan1, Huafei Huang2

  • 1Department of Pediatrics, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, 1665 Kongjiang Road, Yangpu District, Shanghai, 200092, China.

Insights

Antimicrobial susceptibility in Chinese neonates showed overall improvement over a decade, with notable increases in susceptibility for common pathogens like E. coli and S. aureus. However, Enterococcus spp. resistance to ampicillin declined significantly.

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Resistance Surveillance
  • Clinical Microbiology

Background:

  • Antibiotic resistance poses a significant global health threat.
  • Limited data exists on antimicrobial susceptibility trends in Chinese neonates.
  • Existing research primarily focuses on adult populations.

Purpose of the Study:

  • To assess antimicrobial susceptibility trends in common pathogens affecting full-term neonates in China.
  • To analyze changes in susceptibility over a ten-year period (2012-2021).
  • To provide insights into the effectiveness of antibiotic stewardship in neonatal care.

Main Methods:

  • Cross-sectional survey study involving 17 hospitals in China from January 2012 to December 2021.
  • Joinpoint regression model used to analyze trends and calculate Average Annual Percentage Change (AAPC).
  • Mantel-Haenszel chi-square test compared minimum inhibitory concentrations (MICs) between 2019 and 2021.

Main Results:

  • Escherichia coli with extended-spectrum-beta-lactamase-negative strains increased significantly (AAPC = 62.4%).
  • Increased susceptibility observed for Group B Streptococcus (GBS) to erythromycin and clindamycin, and Staphylococcus aureus to penicillin.
  • Declined susceptibility of Enterococcus spp. to ampicillin (AAPC = -11.7%); no significant improvement for E. coli against ampicillin, gentamicin, and cephalosporin.

Conclusions:

  • Antimicrobial susceptibility of prevalent pathogens in Chinese neonates has generally improved or remained stable over the past decade.
  • These trends suggest the emerging effectiveness of antibiotic stewardship policies and practices.
  • Continued surveillance is crucial for monitoring resistance patterns and guiding treatment strategies.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...